Osiris Provides Update Regarding NASDAQ Listing Matters

Osiris Provides Update Regarding NASDAQ Listing Matters


Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market . As previously disclosed, the Company received notifications from NASDAQ indicating that, as a result of the Company not timely filing with the Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 2015 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2016 and June 30, 2016, the Company failed to comply with the periodic filing requirements in NASDAQ Listing Rule 5250 .



from Biotech News